- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Polatuzumab Vedotin
Total 401 results
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Genentech, Inc.TerminatedLymphomaUnited States
-
Qilu Hospital of Shandong UniversityNot yet recruitingHER2-positive Gastric CancerChina
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
TakedaCompletedHodgkin Disease | Lymphoma, Large-Cell, AnaplasticChina
-
Massachusetts General HospitalSeagen Inc.TerminatedGVHD | Graft-vs-Host DiseaseUnited States
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN); Seagen...CompletedDiffuse Cutaneous Systemic Sclerosis | Scleroderma | dcSScUnited States
-
Changhai HospitalNot yet recruitingHER-2 Protein Overexpression | Esophageal Squamous Carcinoma
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNanfang Hospital of Southern Medical University; The Third Affiliated Hospital... and other collaboratorsNot yet recruiting
-
Multinational Center for Quality of Life Research...UnknownRelapsed or Refractory Hodgkin's LymphomaRussian Federation
-
TakedaCompletedUntreated CD30-Positive Hodgkin's LymphomaJapan
-
TakedaCompletedPeripheral T Cell Lymphoma | Pediatric Hodgkin LymphomaJapan
-
Memorial Sloan Kettering Cancer CenterMethylGene Inc.CompletedHodgkin LymphomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteSeagen Inc.Withdrawn
-
Astellas Pharma IncSeagen Inc.CompletedUrologic Neoplasms | Urinary Bladder Neoplasms | Carcinoma, Transitional Cell | Ureteral Neoplasms | Urothelial Cancer | Urethral Neoplasms | Renal Pelvis NeoplasmsUnited States, Korea, Republic of, Spain, France, Germany, Italy, Japan, Netherlands
-
Merck Sharp & Dohme LLCActive, not recruitingUrothelial CarcinomaAustralia, United States, Chile, Denmark, Israel, Korea, Republic of, Spain
-
Alshimaa Abbas Mohamed EbrahimActive, not recruitingAcne VulgarisEgypt
-
University of CologneRecruitingClassical Hodgkin LymphomaGermany
-
University of BirminghamMillennium Pharmaceuticals, Inc.; Leukaemia Lymphoma ResearchCompleted
-
Seagen Inc.Bristol-Myers SquibbCompletedHodgkin LymphomaUnited States
-
RemeGen Co., Ltd.Recruiting
-
The Lymphoma Academic Research OrganisationCompletedRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaFrance, Belgium
-
Federal Research Institute of Pediatric Hematology...RecruitingHodgkin's LymphomaRussian Federation
-
Seagen Inc.Merck Sharp & Dohme LLC; GenmabRecruitingCarcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Exocrine Pancreatic Cancer | Carcinoma, Squamous Cell of Head and NeckUnited States, Canada, France, Germany, Italy, Spain, United Kingdom, Puerto Rico
-
Seagen Inc.CompletedHodgkin DiseaseUnited States
-
SethiMerck Sharp & Dohme LLCRecruitingT-Cell LymphomaUnited States
-
Arbeitsgemeinschaft medikamentoese TumortherapieTerminatedALK+ Anaplastic Large Cell LymphomaAustria
-
Hoffmann-La RocheRecruitingLarge B-Cell LymphomaBelgium, Korea, Republic of, Australia, China, Japan, United States, Italy, Spain, Taiwan, United Kingdom, France, Mexico, Poland, Germany, Turkey, Brazil, Argentina, Denmark, Canada
-
University of RochesterGenentech, Inc.RecruitingLymphoma, B-Cell | DLBCLUnited States
-
Shanghai Zhongshan HospitalNot yet recruitingColorectal Neoplasms
-
Fondazione Italiana Linfomi ONLUSCompleted
-
Fondazione Italiana Linfomi ONLUSCompleted
-
RemeGen Co., Ltd.RecruitingUrothelial Carcinoma | HER2-expressingChina
-
Lawson Health Research InstituteSeagen Inc.RecruitingDiffuse Cutaneous Systemic SclerosisCanada
-
Washington University School of MedicineCelgene; Seagen Inc.CompletedLymphoma, Large B-Cell, DiffuseUnited States
-
RemeGen Co., Ltd.RecruitingGastric Cancer | Gastroesophageal Junction AdenocarcinomaChina
-
Jason Robert GotlibSeagen Inc.CompletedSystemic Mastocytosis | Mast Cell Leukemia | Aggressive Systemic MastocytosisUnited States
-
Gilead SciencesTerminatedMultiple MyelomaUnited States
-
Nabil AdraTerminatedNonseminomatous Germ Cell Tumor | Testis Cancer | Testicular Cancer | Embryonal Carcinoma | Germ Cell TumorsUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Seagen Inc.Completed
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingFirst-line Treatment | HER2-positive Metastatic Breast CancerChina
-
Bristol-Myers SquibbOno Pharmaceutical Co. Ltd; Seagen Inc.Terminated
-
H. Lee Moffitt Cancer Center and Research InstituteSeagen Inc.TerminatedPilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30Peripheral T-Cell LymphomaUnited States
-
Karyopharm Therapeutics IncSuspendedRelapsed or Refractory Diffuse Large B-Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterTerminated
-
Eric Bernicker, MDMillennium Pharmaceuticals, Inc.; The Methodist Hospital Research InstituteWithdrawnCD30-positive Lymphoma | CD30-positive Solid TumorUnited States
-
Guoxin LiNot yet recruiting
-
University of Kansas Medical CenterSeagen Inc.Recruiting
-
Stichting Hemato-Oncologie voor Volwassenen NederlandRecruiting
-
CuraGen CorporationCompletedBreast CancerUnited States
-
University of WashingtonGenentech, Inc.SuspendedPrimary Mediastinal (Thymic) Large B-Cell Lymphoma | Aggressive Non-Hodgkin Lymphoma | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | High Grade B-Cell Lymphoma, Not Otherwise Specified | T-Cell/Histiocyte-Rich... and other conditionsUnited States